Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern.

Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K; Hautz, Wolf E; Atkinson, Andrew; Hammann, Felix

Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K; Hautz, Wolf E; Atkinson, Andrew; Hammann, Felix.

Afiliação

Schöning V; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Liakoni E; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Baumgartner C; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Exadaktylos AK; Department of Emergency Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Hautz WE; Department of Emergency Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Atkinson A; Pediatric Pharmacology and Pharmacometrics Research Group, University Children's Hospital, Basel, Switzerland.
Hammann F; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

J Transl Med ; 20(1): 427, 2022 09 23.

Article em En | MEDLINE | ID: mdl-36138462

Assuntos

COVID-19; Humanos; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Transl Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google